Sponsored by:

Molecular Imaging: Page 468

IsoRay adds cesium-131 sites
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical has increased the number of sites either producing or getting ready to produce cesium-131.
January 16, 2007
Fuji renames Daiichi subsidiary
By AuntMinnie.com staff writers
Japanese film and technology company Fujifilm has applied its corporate branding to its recently acquired Daiichi Radioisotope Laboratories (DRL) subsidiary, with the division to be known as Fujifilm RI Pharma, effective April 1.
January 16, 2007
Neoprobe gets FDA nod for more Lymphoseek trials
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has received authorization from the U.S. Food and Drug Administration (FDA) to begin patient enrollment in two phase I clinical studies for its Lymphoseek targeting agent.
January 16, 2007
Nuclear pharmacy operators merge to form Triad Isotopes
By AuntMinnie.com staff writers
Three nuclear pharmacy operators have merged operations to form a new company, Triad Isotopes.
January 16, 2007
Peregrine establishes Chinese subsidiary, sues CTL
By AuntMinnie.com staff writers
Peregrine Pharmaceuticals has established a wholly foreign-owned enterprise in the People's Republic of China.
January 11, 2007
Digirad updates 2006 guidance
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad yesterday updated its previous financial guidance for 2006 and provided initial guidance for 2007.
January 11, 2007
SPECT/CT enhances octreotide imaging
By Jonathan S. Batchelor
Indium-111-labeled octreotide imaging has shown greater accuracy than CT or MRI scans in detecting somatostatin receptor-positive neuroendocrine tumors. But anatomic localization of these tumors solely based on octreotide scans is problematic, so these procedures are usually performed with CT or MRI. A recent study suggests that SPECT/CT in octreotide imaging can provide important diagnostic information to clinicians that is unavailable with planar whole-body scans.
January 11, 2007
AuntMinnie.com Molecular Imaging Insider
By Jonathan S. Batchelor
January 7, 2007
IBA nets U.S. proton therapy order
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Applications has been selected by ProCure Treatment Centers to build a four-room proton therapy center in Oklahoma City.
January 7, 2007
Mallinckrodt scores Premier deals
By AuntMinnie.com staff writers
Mallinckrodt has received agreements for five of its imaging products from group purchasing organization Premier Purchasing Partners.
January 3, 2007
Temporal subtraction technique improves diagnostic accuracy, speed
By Jonathan S. Batchelor
Although bone scintigraphy is one of the more widely used nuclear medicine studies, interpreting the images is time-intensive, and detecting interval changes can be problematic. Now researchers from Chicago have developed a computerized temporal subtraction technique used between successive whole-body bone scans that may reduce physicians' reading time and improve their accuracy.
January 3, 2007
Siemens finalizes Bayer buy
By AuntMinnie.com staff writers
Siemens Medical Solutions has completed its acquisition of Bayer Healthcare's diagnostic division.
January 2, 2007
Previous Page
Page 468 of 611
Next Page